IT1260710B - Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. - Google Patents
Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.Info
- Publication number
- IT1260710B IT1260710B ITRM920361A ITRM920361A IT1260710B IT 1260710 B IT1260710 B IT 1260710B IT RM920361 A ITRM920361 A IT RM920361A IT RM920361 A ITRM920361 A IT RM920361A IT 1260710 B IT1260710 B IT 1260710B
- Authority
- IT
- Italy
- Prior art keywords
- compound
- allylamin
- active ingredient
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Lubricants (AREA)
Abstract
Oggetto dell'invenzione sono soluzioni, gel in emulsione o lozioni non grasse per applicazione topica, comprendenti quale agente attivo un composto di formula I (FORMULA I) ed un alcanolo inferiore e, se desiderato, insieme con un agente solubilizzante oppure una fase oleosa, quale il miristato isopropilico, le quali sono utili sistemi di erogazione.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919110884A GB9110884D0 (en) | 1991-05-20 | 1991-05-20 | Pharmaceutical compositions |
GB919111477A GB9111477D0 (en) | 1991-05-29 | 1991-05-29 | Pharmaceutical composition |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM920361A0 ITRM920361A0 (it) | 1992-05-12 |
ITRM920361A1 ITRM920361A1 (it) | 1993-11-12 |
IT1260710B true IT1260710B (it) | 1996-04-22 |
Family
ID=26298929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM920361A IT1260710B (it) | 1991-05-20 | 1992-05-12 | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. |
Country Status (29)
Country | Link |
---|---|
US (2) | US5681849A (it) |
EP (1) | EP0515310B1 (it) |
JP (1) | JP2651311B2 (it) |
KR (1) | KR100303095B1 (it) |
AT (1) | AT400517B (it) |
AU (1) | AU647922B2 (it) |
CA (1) | CA2068957C (it) |
CH (1) | CH683823A5 (it) |
CY (1) | CY1942A (it) |
CZ (2) | CZ283019B6 (it) |
DE (1) | DE4215450B4 (it) |
DK (1) | DK0515310T3 (it) |
ES (1) | ES2186668T3 (it) |
FI (2) | FI102458B (it) |
FR (1) | FR2676646B1 (it) |
GB (1) | GB2255908B (it) |
HK (1) | HK148896A (it) |
HU (1) | HU223343B1 (it) |
IE (1) | IE70913B1 (it) |
IL (1) | IL101903A (it) |
IT (1) | IT1260710B (it) |
LU (1) | LU88114A1 (it) |
MX (1) | MX9202328A (it) |
NO (1) | NO180772C (it) |
PT (1) | PT515310E (it) |
RO (1) | RO111986B1 (it) |
SA (1) | SA92130087B1 (it) |
SK (1) | SK281615B6 (it) |
UA (1) | UA39853C2 (it) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
HU219480B (hu) * | 1991-05-23 | 2001-04-28 | Novartis Ag. | Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására |
US20020048596A1 (en) * | 1994-12-30 | 2002-04-25 | Gregor Cevc | Preparation for the transport of an active substance across barriers |
CN1192766C (zh) * | 1998-10-23 | 2005-03-16 | 伊迪亚股份公司 | 开发、测试和使用用于改进的有效负载和可控制性解缔/缔合速度的大分子和复合聚集体的缔合物的方法 |
DK1031347T3 (da) | 1999-01-27 | 2002-07-08 | Idea Ag | Transnasal transport/immunisering med meget tilpasselige bærere |
ES2173678T3 (es) | 1999-01-27 | 2002-10-16 | Idea Ag | Vacunacion no invasiva a traves de la piel. |
MXPA02000053A (es) * | 1999-07-05 | 2003-07-21 | Idea Ag | Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables. |
GB0001928D0 (en) * | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
GB0003932D0 (en) | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
DE10011081A1 (de) * | 2000-03-09 | 2001-09-13 | Aventis Pharma Gmbh | Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel |
US8257688B2 (en) * | 2000-03-27 | 2012-09-04 | Taro Pharmaceuticals Industries | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
US7074392B1 (en) | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
DE10035991A1 (de) | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
KR100389671B1 (ko) * | 2000-11-24 | 2003-06-27 | 한미약품 주식회사 | 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물 |
US6490390B1 (en) * | 2001-01-05 | 2002-12-03 | Phaethon Communications | Grating writing systems based on an acousto-optic element |
KR100423666B1 (ko) | 2001-02-07 | 2004-03-18 | 보령제약 주식회사 | 항진균 외용 제제 |
GB0103046D0 (en) | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
BRPI0101486B1 (pt) * | 2001-04-17 | 2017-09-19 | Cristália Produtos Químicos Farmacêuticos Ltda. | Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns |
US7244703B2 (en) | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
US20040105881A1 (en) * | 2002-10-11 | 2004-06-03 | Gregor Cevc | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
EP1663142A2 (en) * | 2003-06-23 | 2006-06-07 | MacroChem Corporation | Compositons and methods for topical administration |
WO2005002561A1 (ja) * | 2003-07-03 | 2005-01-13 | Taisho Pharmaceutical Co.,Ltd. | 外用抗真菌剤組成物 |
KR100581169B1 (ko) * | 2003-07-07 | 2006-05-17 | 한국유나이티드제약 주식회사 | 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법 |
JP2005104916A (ja) * | 2003-09-30 | 2005-04-21 | Kobayashi Pharmaceut Co Ltd | 抗真菌組成物 |
US7112561B2 (en) | 2003-12-08 | 2006-09-26 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for insulin treatment |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
CA2570245A1 (en) * | 2004-07-02 | 2006-01-12 | Warner-Lambert Company Llc | Compositions and methods for treating pathological infections |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
JP2008519784A (ja) * | 2004-11-12 | 2008-06-12 | イデア アクチェンゲゼルシャフト | 皮膚状態の治療における拡張表面凝集体 |
WO2006103638A2 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
JP2009502258A (ja) * | 2005-07-21 | 2009-01-29 | ノミール・メディカル・テクノロジーズ・インコーポレーテッド | 標的部位の生物学的汚染物質のレベルを下げる方法 |
US7359057B2 (en) * | 2005-08-26 | 2008-04-15 | Ball Aerospace & Technologies Corp. | Method and apparatus for measuring small shifts in optical wavelengths |
EP1931309B1 (en) | 2005-09-29 | 2012-09-26 | Novartis AG | Antifungal composition |
EP2121572A2 (en) * | 2006-12-08 | 2009-11-25 | Auspex Pharmaceuticals Inc. | Preparation and utility of substituted allylamines |
JP2010519288A (ja) * | 2007-02-21 | 2010-06-03 | パワー ペイパー リミテッド | イオン導入法のためのテルビナフィン製剤 |
WO2008105038A1 (ja) * | 2007-02-23 | 2008-09-04 | Nichiban Company Limited | 抗真菌症用貼付剤 |
US20080261986A1 (en) * | 2007-03-30 | 2008-10-23 | Friden Phillip M | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
US20090082469A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched terbinafine |
EP2340043A4 (en) * | 2008-10-31 | 2012-09-19 | Moberg Derma Ab | TOPICAL COMPOSITION COMPRISING A COMBINATION OF AT LEAST TWO PENETRATION AGENTS |
PT2735309T (pt) | 2012-11-27 | 2016-09-26 | Cos Alfonso Eduardo | Composição farmacêutica para o tratamento da tendinite calcificada e/ou da bursite calcificada |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
US20170266106A1 (en) | 2014-12-01 | 2017-09-21 | Achelios Therapeutics, Inc. | Methods and compositions for treating migraine and conditions associated with pain |
GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
CA3045004A1 (en) * | 2015-12-16 | 2017-06-22 | Achelios Therapeutics, Inc. | Methods and compositions for treating peripheral neuropathy |
TWI656883B (zh) * | 2017-08-21 | 2019-04-21 | 高雄醫學大學 | 光敏劑或其前驅藥物的醫藥載體 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472793A (en) * | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
DE2716943C2 (de) * | 1976-04-28 | 1986-08-14 | Sandoz-Patent-GmbH, 7850 Lörrach | N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung |
DE3069633D1 (en) * | 1979-08-22 | 1984-12-20 | Sandoz Ag | Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
FR2572933B1 (fr) * | 1981-04-06 | 1988-03-18 | Sandoz Sa | Compositions pharmaceutiques topiques a base de tizanidine |
FR2502951B1 (fr) * | 1981-04-06 | 1985-12-06 | Sandoz Sa | Compositions pharmaceutiques topiques sous forme d'une micro-emulsion |
JPS6058914A (ja) * | 1983-09-12 | 1985-04-05 | Shionogi & Co Ltd | イミダゾ−ル系抗真菌性外用ゲル製剤 |
US4912124A (en) * | 1984-02-23 | 1990-03-27 | Ortho Pharmaceutical Corporation | Antifungal dermatological solution |
JPS61151117A (ja) * | 1984-12-25 | 1986-07-09 | Bayer Yakuhin Kk | 抗真菌ゲル製剤 |
US4760096A (en) * | 1985-09-27 | 1988-07-26 | Schering Corporation | Moisturizing skin preparation |
JP2633555B2 (ja) * | 1987-03-23 | 1997-07-23 | 株式会社東芝 | 半導体装置の製造方法 |
EP0325949B1 (en) * | 1988-01-13 | 1991-12-18 | Schwarz Pharma Ag | Concentrated solutions of corticosteroids and method of making them |
US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
US5116603A (en) * | 1989-01-31 | 1992-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Oral antifungal preventative, and method of use |
HUT58201A (en) * | 1989-03-03 | 1992-02-28 | Sandoz Ag | Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives |
FR2646603B1 (fr) * | 1989-05-03 | 1991-07-12 | Oreal | Composition nettoyante |
CA2020888A1 (en) * | 1989-07-27 | 1991-01-28 | Philippe Guerry | Substituted aminoalkoxybenzene derivatives |
FR2666962B1 (fr) * | 1990-09-26 | 1996-06-14 | Oreal | Composition antifongique sous forme de spray sec. |
FR2673537B1 (fr) * | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
-
1992
- 1992-05-06 HU HU9201518A patent/HU223343B1/hu active IP Right Grant
- 1992-05-11 DE DE4215450A patent/DE4215450B4/de not_active Expired - Lifetime
- 1992-05-12 IT ITRM920361A patent/IT1260710B/it active IP Right Grant
- 1992-05-13 LU LU88114A patent/LU88114A1/fr unknown
- 1992-05-13 FR FR9205902A patent/FR2676646B1/fr not_active Expired - Lifetime
- 1992-05-15 CH CH1564/92A patent/CH683823A5/de not_active IP Right Cessation
- 1992-05-18 CZ CS921491A patent/CZ283019B6/cs not_active IP Right Cessation
- 1992-05-18 IL IL10190392A patent/IL101903A/en not_active IP Right Cessation
- 1992-05-18 NO NO921958A patent/NO180772C/no not_active IP Right Cessation
- 1992-05-18 ES ES92810372T patent/ES2186668T3/es not_active Expired - Lifetime
- 1992-05-18 GB GB9210579A patent/GB2255908B/en not_active Expired - Lifetime
- 1992-05-18 AU AU16317/92A patent/AU647922B2/en not_active Expired
- 1992-05-18 FI FI922252A patent/FI102458B/fi not_active IP Right Cessation
- 1992-05-18 SK SK1491-92A patent/SK281615B6/sk not_active IP Right Cessation
- 1992-05-18 EP EP92810372A patent/EP0515310B1/en not_active Expired - Lifetime
- 1992-05-18 CZ CZ971292A patent/CZ285275B6/cs not_active IP Right Cessation
- 1992-05-18 DK DK92810372T patent/DK0515310T3/da active
- 1992-05-18 RO RO92-200691A patent/RO111986B1/ro unknown
- 1992-05-18 MX MX9202328A patent/MX9202328A/es unknown
- 1992-05-18 PT PT92810372T patent/PT515310E/pt unknown
- 1992-05-19 KR KR1019920008401A patent/KR100303095B1/ko not_active IP Right Cessation
- 1992-05-19 CA CA002068957A patent/CA2068957C/en not_active Expired - Lifetime
- 1992-05-19 JP JP4125921A patent/JP2651311B2/ja not_active Expired - Lifetime
- 1992-05-19 AT AT0102392A patent/AT400517B/de not_active IP Right Cessation
- 1992-07-01 IE IE921599A patent/IE70913B1/en not_active IP Right Cessation
- 1992-09-07 SA SA92130087A patent/SA92130087B1/ar unknown
-
1993
- 1993-06-18 UA UA93003146A patent/UA39853C2/uk unknown
-
1994
- 1994-04-18 US US08/228,841 patent/US5681849A/en not_active Expired - Lifetime
-
1996
- 1996-08-08 HK HK148896A patent/HK148896A/xx not_active IP Right Cessation
-
1997
- 1997-05-16 CY CY194297A patent/CY1942A/xx unknown
- 1997-07-22 US US08/898,348 patent/US5856355A/en not_active Expired - Lifetime
-
1998
- 1998-08-18 FI FI981777A patent/FI981777A/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1260710B (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
FI941771A0 (fi) | Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten | |
NO995367D0 (no) | Aktivert Vitamin D3-emulsjonstype lotioner | |
TW429152B (en) | A tretinoin aqueous gel composition for therapeutic topical administration to the skin | |
PL335575A1 (en) | Hydrophilic two-component systems for use in administration of cyclosporine | |
NZ236823A (en) | Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance | |
DE69418468T2 (de) | Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
DK0634925T3 (da) | Supermættede topiske præparater | |
HUP0001970A2 (hu) | Gombaellenes szert és foszfolipidet tartalmazó készítmények | |
ITRM920383A1 (it) | Preparati liposomici contenenti un composto allilamminico come agente farmacologicamente attivo | |
SE9800729D0 (sv) | New topical formulation I | |
IT1272149B (it) | Composizione farmeceutiche ad attivita' analgesica | |
ATE127683T1 (de) | Stabile emulgierte tretinoin-cremeformulierungen. | |
FR2689762B1 (fr) | Compositions cosmetiques contenant une vitamine e polyethoxylee. | |
DE69327495T2 (de) | Arzneimittel die Glicentin als aktiven Wirkstoff enthalten | |
ITMI950379A0 (it) | Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico | |
DK0647129T3 (da) | Præparat til topisk anvendelse | |
ES2133928T3 (es) | Agente para el tratamiento del cabello en 2 fases. | |
FR2696345B3 (fr) | Composition cosmétique à ingrédient actif enrobé. | |
ITMI951210A0 (it) | Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi | |
FR2685204B1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. | |
ITPD920141A0 (it) | Formulazione farmaceutiche per la somministraziane orale di calcitoni-na | |
IT1270641B (it) | Uso della midesteina come cicatrizzante e composizioni farmaceutiche topiche relative | |
ITBA920007A0 (it) | Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970526 |